Transcatheter aortic valve replacement: Current application and future directions

Current Cardiology Reports

Volumn 15, Issue 4, 2013, Pages

  Fassa, Amir Ali ^a   Himbert, Dominique ^a   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Aortic stenosis; Aortic valve replacement; High risk; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; METHODOLOGY; PROSTHESIS; REVIEW;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN;

MLCS; MLOWN;

EID: 84880439644     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0353-7     Document Type: Article

References (41)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-8. (Pubitemid 35440280)
2. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011;32:140-7.
3. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;60:483-92.
4. Himbert D, Roy D, Brecker S, Brochet E, Depoix JP, Radu C, et al. Tools & techniques: transcatheter aortic valve implantation: transfemoral approach. EuroIntervention. 2011;6:784-5.
5. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, et al. European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463-70. (Pubitemid 351806497)
6. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, et al. ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200-54.
7. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on theManagement of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451-96.
8. Green P, Woglom AE, Genereux P, Daneault B, Paradis JM, Schnell S, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5:974-81.
9. Delgado V, Ewe SH, Ng AC, van der Kley F, Marsan NA, Schuijf JD, et al. Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention. 2010;6:643-52.
10. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, Detaint D, et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol. 2010;55:186-94.
11. Kempfert J, Van Linden A, Lehmkuhl L, Rastan AJ, Holzhey D, Blumenstein J, et al. Aortic annulus sizing: echocardiographic vs computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg. 2012;42:627-33.
12. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3:359-66.
13. Bruschi G, de Marco F, Botta L, Cannata A, Oreglia J, Colombo P, et al. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation. Ann Thorac Surg. 2012;94:497-503.
14. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-69.
15. Leon MB, Smith CR, MackM, Miller DC, Moses JW, Svensson LG, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
16. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. PARTNER Trial Investigators. Transcatheter vs surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
17. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95.
18. ThomasM, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. Thirty-day results of the SAPIENaortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-9.
19. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-33.
20. Linke A, on behalf of the ADVANCE steering committee and investigators. Medtronic CoreValve ADVANCE Study. Communication TCT Congress, 2012.
21. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-15.
22. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability fromthe Canadian Multicenter Experience. J Am Coll Cardiol. 2012;60:1864-75.
23. Iung B, Vahanian A. Towards improved risk scores: the quest for the grail continues. Eur Heart J. 2013;34:10-1.
24. Gurvitch R, Cheung A, Ye J, Wood DA, Willson AB, Toggweiler S, et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol. 2011;58:2196-209.
25. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 1). JACC Cardiovasc Interv. 2011;4:721-32.
26. Piazza N, Bleiziffer S, Brockmann G, Hendrick R, Deutsch MA, Opitz A, et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2). JACC Cardiovasc Interv. 2011;4:733-42.
27. Descoutures F, Himbert D, Radu C, Iung B, Cueff C, Messika-Zeitoun D, et al. Transarterial Medtronic CoreValve System implantation for degenerated surgically implanted bioprostheses. Circulation Cardiovasc Intv. 2011;4:488-94.
28. Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, et al. Transcather aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335-44.
29. Wijesinghe N, Ye J, Rodés-Cabau J, Velianou JL, Natarajan MK, Dumont E, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2010;3:1122-5.
30. Himbert D, Pontnau F, Messika-Zeitoun D, Descoutures F, Détaint D, Cueff C, et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol. 2012;110:877-83.
31. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, et al. German transcatheter aortic valve interventions-registry investigators. Transcatheter aortic valve implantation: first results from a multi-center real-world registry. Eur Heart J. 2011;32:198-204.
32. vanMieghem NM, Head SJ, van der Boon RM, Piazza N, de Jaegere PP, Carrel T, et al. The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention. 2012;8:258-66.
33. Sinning JM, Werner N, Nickenig G, Grube E. Next-generation transcatheter heart valves: current trials in Europe and the USA. Methodist Debakey Cardiovasc J. 2012;8:9-12.
34. Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv. 2011;4:751-7.
35. Daneault B, Kirtane AJ, Kodali SK, Williams MR, Genereux P, Reiss GR, et al. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol. 2011;58:2143-50.
36. Nuis RJ, Van Mieghem NM, Schultz CJ, Moelker A, van der Boon RM, van Geuns RJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1637-43.
37. Amat-Santos IJ, Rodés-Cabau J, Urena M, DeLarochellière R, Doyle D, Bagur R, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178-88.
38. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, et al. Partner trial investigators and patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) vs surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-43.
39. Naber CK, Ghanem A, Abizaid AA, Wolf A, Sinning JM, Werner N, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. Euro-Intervention. 2012;8:43-50.
40. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, García- García H, et al. Persistent conduction abnormalities and requirements for pacemaking 6 months after transcatheter aortic valve implantation. EuroIntervention. 2010;6:475-84.
41. Vahanian A, Himbert D, Brochet E, Depoix JP, Iung B, Nataf P. Transcatheter aortic valve implantation: our vision of the future. Arch Cardiovasc Dis. 2012;105:181-6.